550 related articles for article (PubMed ID: 37833700)
1. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
4. Predicting early Alzheimer's with blood biomarkers and clinical features.
AlMansoori ME; Jemimah S; Abuhantash F; AlShehhi A
Sci Rep; 2024 Mar; 14(1):6039. PubMed ID: 38472245
[TBL] [Abstract][Full Text] [Related]
5. XGBoost-SHAP-based interpretable diagnostic framework for alzheimer's disease.
Yi F; Yang H; Chen D; Qin Y; Han H; Cui J; Bai W; Ma Y; Zhang R; Yu H
BMC Med Inform Decis Mak; 2023 Jul; 23(1):137. PubMed ID: 37491248
[TBL] [Abstract][Full Text] [Related]
6. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
7. Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects.
Wang Y; Gao R; Wei T; Johnston L; Yuan X; Zhang Y; Yu Z;
J Transl Med; 2024 Mar; 22(1):265. PubMed ID: 38468358
[TBL] [Abstract][Full Text] [Related]
8. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
9. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
10. A Machine Learning Classifier for Predicting Stable MCI Patients Using Gene Biomarkers.
Lin RH; Wang CC; Tung CW
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457705
[TBL] [Abstract][Full Text] [Related]
11. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
[TBL] [Abstract][Full Text] [Related]
12. A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.
Ramzan F; Khan MUG; Rehmat A; Iqbal S; Saba T; Rehman A; Mehmood Z
J Med Syst; 2019 Dec; 44(2):37. PubMed ID: 31853655
[TBL] [Abstract][Full Text] [Related]
13. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
[TBL] [Abstract][Full Text] [Related]
14. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
Johnstone D; Milward EA; Berretta R; Moscato P;
PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
[TBL] [Abstract][Full Text] [Related]
15. Predicting Alzheimer's disease progression using multi-modal deep learning approach.
Lee G; Nho K; Kang B; Sohn KA; Kim D;
Sci Rep; 2019 Feb; 9(1):1952. PubMed ID: 30760848
[TBL] [Abstract][Full Text] [Related]
16. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
Abdelaziz M; Wang T; Elazab A
J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
[TBL] [Abstract][Full Text] [Related]
18. Explainable AI-based Deep-SHAP for mapping the multivariate relationships between regional neuroimaging biomarkers and cognition.
Bhattarai P; Thakuri DS; Nie Y; Chand GB
Eur J Radiol; 2024 May; 174():111403. PubMed ID: 38452732
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
Sun Y; Bresell A; Rantalainen M; Höglund K; Lebouvier T; Salter H;
J Alzheimers Dis; 2015; 45(4):1061-76. PubMed ID: 25720397
[TBL] [Abstract][Full Text] [Related]
20. Multimodal attention-based deep learning for Alzheimer's disease diagnosis.
Golovanevsky M; Eickhoff C; Singh R
J Am Med Inform Assoc; 2022 Nov; 29(12):2014-2022. PubMed ID: 36149257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
